Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1989 Dec;57(12):3671–3676. doi: 10.1128/iai.57.12.3671-3676.1989

Immunity to tuberculosis from the perspective of pathogenesis.

E Wiegeshaus 1, V Balasubramanian 1, D W Smith 1
PMCID: PMC259888  PMID: 2680977

Full text

PDF
3671

Images in this article

3672Image
on p.3672
3673Image
on p.3673

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhathena D., Mohapatra L. N., Mital G. S., Ramalingaswami V., Nayak N. C. The pulmonary tuberculous lesion in North India: a study in medico-legal autopsies. II. Bacteriologic aspects. Am Rev Respir Dis. 1970 Jan;101(1):18–26. doi: 10.1164/arrd.1970.101.1.18. [DOI] [PubMed] [Google Scholar]
  2. CROWLE A. J. Tubercle bacillary extracts immunogenic for mice. 1. Factors affecting demonstration of their activity. Tubercle. 1961 Dec;42:470–478. doi: 10.1016/s0041-3879(61)80136-0. [DOI] [PubMed] [Google Scholar]
  3. CROWLE A. J. Tubercle bacillary extracts immunogenic for mice. 3. Chemical degradation studies on the immunogen extracted from tubercle bacilli by trypsin digestion. Tubercle. 1962 Jun;43:178–184. doi: 10.1016/s0041-3879(62)80038-5. [DOI] [PubMed] [Google Scholar]
  4. Canetti G., Sutherland I., Svandova E. Endogenous reactivation and exogenous reinfection: their relative importance with regard to the development of non-primary tuberculosis. Bull Int Union Tuberc. 1972 Feb;47:116–134. [PubMed] [Google Scholar]
  5. Collins F. M. Protection to mice afforded by BCG vaccines against an aerogenic challenge by three mycobacteria of decreasing virulence. Tubercle. 1985 Dec;66(4):267–276. doi: 10.1016/0041-3879(85)90064-9. [DOI] [PubMed] [Google Scholar]
  6. Crowle A. J. Immunization against tuberculosis: what kind of vaccine? Infect Immun. 1988 Nov;56(11):2769–2773. doi: 10.1128/iai.56.11.2769-2773.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dannenberg A. M., Jr Pathogenesis of pulmonary tuberculosis. Am Rev Respir Dis. 1982 Mar;125(3 Pt 2):25–29. doi: 10.1164/arrd.1982.125.3P2.25. [DOI] [PubMed] [Google Scholar]
  8. Edwards M. L., Goodrich J. M., Muller D., Pollack A., Ziegler J. E., Smith D. W. Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guérin. J Infect Dis. 1982 May;145(5):733–741. doi: 10.1093/infdis/145.2.733. [DOI] [PubMed] [Google Scholar]
  9. Hart P. D., Sutherland I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J. 1977 Jul 30;2(6082):293–295. doi: 10.1136/bmj.2.6082.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ho R. S., Fok J. S., Harding G. E., Smith D. W. Host-parasite relationships in experimental airborne tuberculosis. VII. Fate of Mycobacterium tuberculosis in primary lung lesions and in primary lesion-free lung tissue infected as a result of bacillemia. J Infect Dis. 1978 Aug;138(2):237–241. doi: 10.1093/infdis/138.2.237. [DOI] [PubMed] [Google Scholar]
  11. Ladefoged A., Bunch-Christensen K., Guld J. Tuberculin sensitivity in guinea-pigs after vaccination with varying doses of BCG of 12 different strains. Bull World Health Organ. 1976;53(4):435–443. [PMC free article] [PubMed] [Google Scholar]
  12. MACKANESS G. B. THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE. J Exp Med. 1964 Jul 1;120:105–120. doi: 10.1084/jem.120.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. MITCHISON D. A. THE VIRULENCE OF TUBERCLE BACILLI FROM PATIENTS WITH PULMONARY TUBERCULOSIS IN INDIA AND OTHER COUNTRIES. Bull Int Union Tuberc. 1964 Sep;35:287–306. [PubMed] [Google Scholar]
  14. Palmer C. E., Long M. W. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis. 1966 Oct;94(4):553–568. doi: 10.1164/arrd.1966.94.4.553. [DOI] [PubMed] [Google Scholar]
  15. Portelance V., Brasseur R., Boulanger R. P. Factors affecting the immunizing activity of ribosomal fractions isolated from Mycobacterium tuberculosis var. bovis strain BCG. Can J Microbiol. 1975 Oct;21(10):1492–1499. doi: 10.1139/m75-221. [DOI] [PubMed] [Google Scholar]
  16. Prabhakar R., Venkataraman P., Vallishayee R. S., Reeser P., Musa S., Hashim R., Kim Y., Dimmer C., Wiegeshaus E., Edwards M. L. Virulence for guinea pigs of tubercle bacilli isolated from the sputum of participants in the BCG trial, Chingleput District, South India. Tubercle. 1987 Mar;68(1):3–17. doi: 10.1016/0041-3879(87)90003-1. [DOI] [PubMed] [Google Scholar]
  17. RAMAKRISHNAN C. V., BHATIA A. L., FOX W., MITCHISON D. A., RADHAKRISHNA S., SELKON J. B., SELKON J. B., SUBBAIAH T. V., VELU S., WALLACE J. G. The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. 3. Virulence related to pretreatment status of disease and to response to chemotherapy. Bull World Health Organ. 1961;25:323–338. [PMC free article] [PubMed] [Google Scholar]
  18. Ribi E., Anacker R. L., Barclay W. R., Brehmer W., Harris S. C., Leif W. R., Simmons J. Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the Rheusus monkey. J Infect Dis. 1971 May;123(5):527–538. doi: 10.1093/infdis/123.5.527. [DOI] [PubMed] [Google Scholar]
  19. Smith D. W., Ladefoged A., Reeser P., Edwards M. Does trypsin extract soluble antigen meet the criteria of immunogenicity without allergenicity? Tubercle. 1984 Jun;65(2):105–110. doi: 10.1016/0041-3879(84)90061-8. [DOI] [PubMed] [Google Scholar]
  20. Smith D. W., McMurray D. N., Wiegeshaus E. H., Grover A. A., Harding G. E. Host-parasite relationships in experimental airborne tuberculosis. IV. Early events in the course of infection in vaccinated and nonvaccinated guinea pigs. Am Rev Respir Dis. 1970 Dec;102(6):937–949. doi: 10.1164/arrd.1970.102.6.937. [DOI] [PubMed] [Google Scholar]
  21. Smith D. W. Protective effect of BCG in experimental tuberculosis. Adv Tuberc Res. 1985;22:1–97. [PubMed] [Google Scholar]
  22. Smith D. W., Wiegeshaus E. H. What animal models can teach us about the pathogenesis of tuberculosis in humans. Rev Infect Dis. 1989 Mar-Apr;11 (Suppl 2):S385–S393. doi: 10.1093/clinids/11.supplement_2.s385. [DOI] [PubMed] [Google Scholar]
  23. Smith D., Harding G., Chan J., Edwards M., Hank J., Muller D., Sobhi F. Potency of 10 BCG vaccines as evaluated by their influence on the bacillemic phase of experimental airborne tuberculosis in guinea-pigs. J Biol Stand. 1979 Jul;7(3):179–197. doi: 10.1016/s0092-1157(79)80021-9. [DOI] [PubMed] [Google Scholar]
  24. Sunderam G., McDonald R. J., Maniatis T., Oleske J., Kapila R., Reichman L. B. Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). JAMA. 1986 Jul 18;256(3):362–366. [PubMed] [Google Scholar]
  25. Wang G. Z., Balasubramanian V., Smith D. W. The protective and allergenic potency of four BCG substrains in use in China determined in two animal models. Tubercle. 1988 Dec;69(4):283–291. doi: 10.1016/0041-3879(88)90051-7. [DOI] [PubMed] [Google Scholar]
  26. Wiegeshaus E. H., Harding G., McMurray D., Grover A. A., Smith D. W. A co-operative evaluation of test systems used to assay tuberculosis vaccines. Bull World Health Organ. 1971;45(5):543–550. [PMC free article] [PubMed] [Google Scholar]
  27. Wiegeshaus E. H., Smith D. W. Evaluation of the protective potency of new tuberculosis vaccines. Rev Infect Dis. 1989 Mar-Apr;11 (Suppl 2):S484–S490. doi: 10.1093/clinids/11.supplement_2.s484. [DOI] [PubMed] [Google Scholar]
  28. YOUMANS G. P., YOUMANS A. S. The measurement of the response of immunized mice to infection with Mycobacterium tuberculosis va. hominis. J Immunol. 1957 May;78(5):318–329. [PubMed] [Google Scholar]
  29. ten Dam H. G., Pio A. Pathogenesis of tuberculosis and effectiveness of BCG vaccination. Tubercle. 1982 Sep;63(3):225–233. doi: 10.1016/s0041-3879(82)80036-6. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES